The table below shows BioXcel Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$642.00K
$2.27M
$1.38M
$375.00K
-
-
Cost of revenue
$164.00K
$2.14M
$1.26M
$20.00K
-
-
Gross profit
-
-
-
-
-
-
R&D
$30.25M
$30.43M
$84.33M
$91.24M
$52.71M
$57.99M
SG&A
BTAI annual revenue (10-K history)
BioXcel Therapeutics, Inc. reported annual revenue of $642.00K for fiscal year 2025. That is down 71.7% from $2.27M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.